HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Evaluation of von Willebrand factor phenotypes and genotypes in Hemophilia A patients with and without identified F8 mutations.

AbstractBACKGROUND:
Hemophilia A (HA) is an X-linked bleeding disorder caused by a deficiency in factor VIII (FVIII). von Willebrand disease (VWD) is characterized by a quantitative or qualitative defect in von Willebrand factor (VWF). Patients with VWD with severely low VWF or VWD Type 2N (VWD2N), a VWD subtype distinguished by defective VWF binding to FVIII, may have reduced FVIII levels secondary to their VWD. These patients superficially resemble patients with HA and pose a potential for misdiagnosis.
OBJECTIVES:
To investigate the unexplained cause of bleeding in HA patients without known FVIII mutations by assessing plasma VWF antigen (VWF:Ag), FVIII binding capacities and VWF genotypes.
PATIENTS/METHODS:
Thirty-seven of 1027 patients with HA studied as part of the Hemophilia Inhibitor Research Study lacked identifiable F8 mutations. These patients (cases) and 73 patients with identified F8 mutations (controls) were evaluated for VWF:Ag, a patient's VWF capacity to bind FVIII (VWF:FVIIIB) and VWF sequence.
RESULTS:
Four cases had VWF:Ag < 3 IU dL(-1) and VWF mutations consistent with Type 3 VWD. Six cases and one control were heterozygous for mutations previously reported to cause Type 1 VWD (VWD1) (n = five cases and one control) or predicted to be deleterious by Polyphen2 and SIFT prediction tools (n = 1 case). One control had VWF:Ag < 30 IU dL(-1) and seven patients (four cases and three controls), including two cases who were heterozygous for a known VWD2N mutation, had reduced VWF:FVIIIB.
CONCLUSIONS:
These data emphasize that some patients diagnosed with HA require VWF assessments in order to achieve a comprehensive diagnosis and an optimal treatment strategy.
AuthorsB Boylan, A S Rice, C De Staercke, M E Eyster, H M Yaish, C M Knoll, C J Bean, C H Miller, Hemophilia Inhibitor Research Study Investigators
JournalJournal of thrombosis and haemostasis : JTH (J Thromb Haemost) Vol. 13 Issue 6 Pg. 1036-42 (Jun 2015) ISSN: 1538-7836 [Electronic] England
PMID25780857 (Publication Type: Comparative Study, Journal Article, Multicenter Study, Research Support, U.S. Gov't, P.H.S.)
Copyright© 2015 International Society on Thrombosis and Haemostasis.
Chemical References
  • Biomarkers
  • von Willebrand Factor
  • F8 protein, human
  • Factor VIII
Topics
  • Adolescent
  • Adult
  • Biomarkers (blood)
  • Blood Coagulation (genetics)
  • Blood Coagulation Tests
  • Case-Control Studies
  • Child
  • DNA Mutational Analysis
  • Factor VIII (genetics, metabolism)
  • Genetic Predisposition to Disease
  • Hemophilia A (blood, diagnosis, genetics)
  • Hemorrhage (blood, diagnosis, genetics)
  • Heterozygote
  • Homozygote
  • Humans
  • Male
  • Mutation
  • Phenotype
  • Predictive Value of Tests
  • Protein Binding
  • United States
  • Young Adult
  • von Willebrand Factor (genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: